VINDESINE for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 25 adverse event reports in the FDA FAERS database where VINDESINE was used for Neoplasm malignant.
Most Reported Side Effects for VINDESINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Myelosuppression | 429 | 22.1% | 5 | 263 |
| Off label use | 148 | 7.6% | 21 | 60 |
| Bone marrow failure | 141 | 7.3% | 20 | 79 |
| Pyrexia | 138 | 7.1% | 6 | 94 |
| Anaemia | 137 | 7.0% | 23 | 41 |
| Leukopenia | 127 | 6.5% | 14 | 31 |
| White blood cell count decreased | 124 | 6.4% | 3 | 54 |
| Febrile neutropenia | 115 | 5.9% | 14 | 65 |
| Pneumonia | 110 | 5.7% | 30 | 28 |
| Thrombocytopenia | 93 | 4.8% | 22 | 23 |
| Neutropenia | 89 | 4.6% | 16 | 28 |
| Neutrophil count decreased | 87 | 4.5% | 5 | 28 |
| Drug ineffective | 85 | 4.4% | 23 | 29 |
| Infection | 69 | 3.6% | 30 | 25 |
| Disease progression | 67 | 3.4% | 22 | 16 |
Other Indications for VINDESINE
Diffuse large b-cell lymphoma (279)
Acute lymphocytic leukaemia (272)
Non-hodgkin's lymphoma (131)
Chemotherapy (118)
Lymphoma (104)
B-cell lymphoma (93)
Hodgkin's disease (74)
Neuroblastoma (65)
Adult t-cell lymphoma/leukaemia (61)
Burkitt's lymphoma (58)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)